|
1.
|
|
22 p, 4.7 MB |
Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples
/
Olivan, M (Hospital Universitari Vall d'Hebron) ;
García, Marta (Institut de Recerca Sant Joan de Déu) ;
Suárez, Leticia (Hospital Universitari Vall d'Hebron) ;
Guiu, Marc (Institut de Recerca Biomèdica) ;
Gros, Laura (Hospital Universitari Vall d'Hebron) ;
Méndez Fernández, Olga (Hospital Universitari Vall d'Hebron) ;
Rigau, Marina (Hospital Universitari de Bellvitge) ;
Reventós, Jaume (Hospital Universitari de Bellvitge) ;
Segura, Miguel F. (Hospital Universitari Vall d'Hebron) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron) ;
de la Cruz, Xavier (Hospital Universitari Vall d'Hebron) ;
Gomis, Roger R. (Hospital Universitari de Bellvitge) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ;
Rodríguez-Barrueco, Ruth (Hospital Universitari de Bellvitge) ;
Santamaría, Anna (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Prostate cancer (PCa) is the most prevalent cancer in males worldwide, and it was the fifth leading cause of cancer mortality in this group in 2020. Near 70% of advanced-stage PCa patients will undergo bone metastasis, suffering pathological complications that severely affect patients' quality of life and probably progress in most cases to lethal PCa. [...]
2021 -  10.3390/cancers13246202
Cancers, Vol. 13 (december 2021)
|
|
|
2.
|
|
16 p, 1.3 MB |
Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues
/
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Reventós Puigjaner, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Prostate cancer (PCa) is the most frequently diagnosed type of cancer in developed countries. The decisive method of diagnosis is based on the results of biopsies, morphologically evaluated to determine the presence or absence of cancer. [...]
2013 - 10.1155/2013/283635
BioMed Research International, Vol. 2013 (november 2013)
|
|
|
3.
|
|
13 p, 2.0 MB |
Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis
/
Altadill, Tatiana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Dowdy, Tyrone M. (Georgetown University Medical Center) ;
Gill, Kirandeep (Georgetown University Medical Center) ;
Reques, Armando (Hospital Universitari Vall d'Hebron) ;
Menon, Smrithi S. (Georgetown University Medical Center) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lopez-Gil, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Matias-Guiu, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ;
Cabrera Díaz, Silvia (Vall d'Hebron Institut d'Oncologia) ;
Garcia, Angel (Hospital Universitari Vall d'Hebron) ;
Reventos, Jaume (Universitat Internacional de Catalunya) ;
Byers, Stephen W. (Georgetown-Lombardi Comprehensive Cancer Center) ;
Gil-Moreno, Antonio 1965- (Vall d'Hebron Institut d'Oncologia) ;
Cheema, Amrita K. (Georgetown-Lombardi Comprehensive Cancer Center) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) remains the most common malignancy of the genital tract among women in developed countries. Although much research has been performed at genomic, transcriptomic and proteomic level, there is still a significant gap in the metabolomic studies of EC. [...]
2017 - 10.1038/s41598-017-09169-2
Scientific reports, Vol. 7 (august 2017)
|
|
|
4.
|
|
14 p, 1.3 MB |
Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools
/
Besso, María josé (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Montivero, Luciana (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Lacunza, Ezequiel (Centro de Investigaciones Inmunológicas, Básicas y Aplicadas, Facultad de Ciencias Médicas, Universidad Nacional de La Plata) ;
Argibay, María cecilia (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Abba, Martín (Centro de Investigaciones Inmunológicas, Básicas y Aplicadas, Facultad de Ciencias Médicas, Universidad Nacional de La Plata) ;
Furlong, Laura I (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bello, Ricardo (Departamento de Metodología, Estadística y Matemática, Universidad de Tres de Febrero) ;
Vazquez-Levin, Mónica Hebe (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth most common cancer in women worldwide. Early diagnosis is critical in recurrent EC management. The present study aimed to identify biomarkers of EC early recurrence using a workflow that combined text and data mining databases (DisGeNET, Gene Expression Omnibus), a prioritization algorithm to select a set of putative candidates (ToppGene), protein-protein interaction network analyses (Search Tool for the Retrieval of Interacting Genes, cytoHubba), association analysis of selected genes with clinicopathological parameters, and survival analysis (Kaplan-Meier and Cox proportional hazard ratio analyses) using a The Cancer Genome Atlas cohort. [...]
2020 - 10.3892/or.2020.7648
Oncology Reports, Vol. 44 (june 2020) , p. 873-886
|
|
|
5.
|
|
0 p, 1.1 MB |
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness : Its Relationship With TGF-β1 and NF-κB Pathways
/
Besso, María josé (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ;
Rosso, M. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ;
Lapyckyj, L. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Matos, M. L. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ;
Mercogliano, M. F. (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Schillaci, R. (Instituto de Biología y Medicina Experimental (Buenos Aires, Argentina)) ;
Reventós Puigjaner, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ;
Wernicke, A. (Hospital Italiano de Buenos Aires (Argentina)) ;
Orti, R. (Hospital Italiano de Buenos Aires (Argentina)) ;
Vazquez-Levin, M. H. (Laboratorio de Estudios de la Interacción Celular en Reproducción y Cáncer. Instituto de Biología y Medicina Experimental (IBYME; CONICET-FIBYME)) ;
Universitat Autònoma de Barcelona
Objective: Endometrial cancer (EC) is the second most common gynecological cancer worldwide. Myometrial invasion (MI) is a key event in EC dissemination. This study aimed to evaluate FXYD5/dysadherin (FXYD5/Dys) expression in EC tissue and uterine aspirate (UA) biopsies and to assess molecular/functional changes associated with its expression in cellular models. [...]
2019 - 10.3389/fonc.2019.01306
Frontiers in Oncology, Vol. 9 (june 2019) , p. 1306
|
|
|
6.
|
|
17 p, 4.8 MB |
ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer
/
Devis Jauregui, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martinez-Garcia, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Quiles, Maria Teresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Arbós i Via, Maria Antònia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Stirbat, Tomita Vasilica (Institut Curie) ;
Brochard-Wyart, Françoise (Institut Curie) ;
García, Ángel (Hospital Universitari Vall d'Hebron) ;
Alonso-Alconada, Lorena (Centro de Investigación Biomédica en Red de Cáncer) ;
Abal Posada, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ;
Díaz-Feijoo, Berta (Hospital Universitari Vall d'Hebron) ;
Thomas, William (Department of Natural Sciences, Colby-Sawyer College, New London, New Hampshire, United States of America) ;
Dufour, Sylvie (Present address: Université Paris Est, Faculté de Médecine, Créteil, France, INSERM, U955, Equipe 6, Créteil, France) ;
Mancebo, Gemma (Hospital del Mar (Barcelona, Catalunya)) ;
Alameda, Francesc (Hospital del Mar (Barcelona, Catalunya)) ;
Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth deadliest cancer in women. The depth of myometrial invasion is one of the most important prognostic factors, being directly associated with tumor recurrence and mortality. [...]
2018 - 10.18632/oncotarget.24625
Oncotarget, Vol. 9 (march 2018) , p. 16648-16664
|
|
|
7.
|
|
17 p, 5.0 MB |
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
/
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Chiva, Cristina (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia-Grau, Iolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Diaz, Sherley (Hospital Universitari Vall d'Hebron) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Bijnsdorp, Irene (Department of Urology, VU University Medical Center, Amsterdam, The Netherlands) ;
Campos, Alexandre (Sanford-Burnham Medical Research Institute, La Jolla, California, USA) ;
Di Mauro, Primiano (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ;
Borrós, Salvador (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ;
Reventós, Jaume (Institut d'Investigació Biomèdica de Bellvitge) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Paciucci, Rosanna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pegtel, Michiel (Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sabidó, Eduard (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Rapid and reliable diagnosis of prostate cancer (PCa) is highly desirable as current used methods lack specificity. In addition, identification of PCa biomarkers that can classify patients into high- and low-risk groups for disease progression at early stage will improve treatment decision-making. [...]
2016 - 10.18632/oncotarget.13634
Oncotarget, Vol. 8 (november 2016) , p. 4960-4976
|
|
|
8.
|
|
14 p, 5.6 MB |
Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples
/
Martinez-Garcia, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lesur, Antoine (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ;
Devis Jauregui, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Campos, Alexandre (Sanford-Burnham Medical Research Institute, La Jolla, California, USA) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron) ;
van Oostrum, Jan (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ;
Matias-Guiu, Xavier (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Domon, Bruno (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ;
Universitat Autònoma de Barcelona
About 30% of endometrial cancer (EC) patients are diagnosed at an advanced stage of the disease, which is associated with a drastic decrease in the 5-year survival rate. The identification of biomarkers in uterine aspirate samples, which are collected by a minimally invasive procedure, would improve early diagnosis of EC. [...]
2016 - 10.18632/oncotarget.10632
Oncotarget, Vol. 7 (july 2016) , p. 53102-53115
|
|
|
9.
|
|
12 p, 3.0 MB |
Exosome-like vesicles in uterine aspirates : a comparison of ultracentrifugation-based isolation protocols
/
Campoy Moncayo, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lanau Angulo, Lucia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Altadill, Tatiana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cubo-Abert, Montserrat (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pérez-Benavente, Assumpció (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia, Angel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Borrós, Salvador (Universitat Ramon Llull. Institut Químic de Sarrià-IQS) ;
Santamaría, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ponce, Jordi (Hospital Universitari de Bellvitge) ;
Matias-Guiu, Xavier (Institut de Recerca Biomèdica de Lleida) ;
Reventós, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Uterine aspirates are used in the diagnostic process of endometrial disorders, yet further applications could emerge if its complex milieu was simplified. Exosome-like vesicles isolated from uterine aspirates could become an attractive source of biomarkers, but there is a need to standardize isolation protocols. [...]
2016 - 10.1186/s12967-016-0935-4
Journal of translational medicine, Vol. 14 (june 2016)
|
|
|
10.
|
|
60 p, 3.6 MB |
Biological properties of extracellular vesicles and their physiological functions
/
Yáñez-Mó, María (Universidad Autónoma de Madrid, Departamento de Biología Molecular) ;
Siljander, Pia R.-M. (University of Helsinki. Department of Biosciences) ;
Andreu, Zoraida (Universidad Autónoma de Madrid, Departamento de Biología Molecular) ;
Zavec, Apolonija Bedina (National Institute of Chemistry (Ljubljana)) ;
Borràs i Serres, Francesc Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Buzás, Edit I (Semmelweis University. Department of Genetics, Cell- and Immunobiology) ;
Buzas, Krisztina (University of Szeged. Faculty of Dentistry) ;
Casal, Enriqueta (CIC bioGUNE) ;
Cappello, Francesco (Euro-Mediterranean Institute of Science and Technology (Palermo)) ;
Carvalho, Joana (Institute of Molecular Pathology and Immunology of the University of Porto) ;
Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cordeiro-da-Silva, Anabela (University of Porto. Department of Biological Sciences) ;
Fais, Stefano (National Institute of Health. Department of Therapeutic Research and Medicines Evaluation (Rome)) ;
Falcón Pérez, Juan M. (CIC bioGUNE) ;
Ghobrial, Irene M. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
Giebel, Bernd (University Hospital Essen (Alemanya)) ;
Gimona, Mario (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine (Salzburg)) ;
Graner, Michael (University of Colorado Denver. Department of Neurosurgery) ;
Gursel, Ihsan (Bilkent University. Department of Molecular Biology and Genetics) ;
Gursel, Mayda (Middle East Technical University. Department of Biological Sciences) ;
Heegaard, Niels H. H. (Statens Serum Institut. Department of Clinical Biochemistry, Immunology & Genetics) ;
Hendrix, An (Universitair Ziekenhuis Gent) ;
Kierulf, Peter (Oslo University Hospital (Oslo, Noruega)) ;
Kokubun, Katsutoshi (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
Kosanovic, Maja (University of Belgrade. Institute for the Application of Nuclear Energy) ;
Kralj-Iglic, Veronika (University of Ljubljana. Faculty of Health Sciences) ;
Krämer-Albers, Eva-Maria (University of Mainz. Molecular Cell Biology and Focus Program Translational Neurosciences) ;
Laitinen, Saara (Finnish Red Cross Blood Service) ;
Lässer, Cecilia (University of Gothenburg. Institute of Medicine at the Sahlgrenska Academy) ;
Lener, Thomas (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine) ;
Ligeti, Erzsébet (Semmelweis University. Department of Physiology) ;
Linē, Aija (Latvian Biomedical Research and Study Centre) ;
Lipps, Georg (University of Applied Sciences and Arts Northwestern Switzerland. Institute of Chemistry and Bioanalytics) ;
Llorente, Alicia (Oslo University Hospital - The Norwegian Radium Hospital. Institute for Cancer Research) ;
Lötvall, Jan (University of Gothenburg. Institute of Medicine at the Sahlgrenska Academy) ;
Manček-Keber, Mateja (EN→FIST Centre of Excellence (Ljubljana)) ;
Marcilla, Antonio (Universitat de València. Departament de Biologia Cel·lular, Biologia Funcional i Antropologia Física) ;
Mittelbrunn, Maria (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Nazarenko, Irina (University of Freiburg. Institute for Environmental Health Sciences and Hospital Infection Control Medical Center) ;
Nolte-'t Hoen, Esther N. M. (Utrecht University. Department of Biochemistry and Cell Biology) ;
Nyman, Tuula A. (University of Helsinki. Institute of Biotechnology) ;
O'Driscoll, Lorraine (Trinity College Dublin. School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute) ;
Olivan, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Oliveira, Carla (University of Porto. Department of Pathology and Oncology) ;
Pállinger, Éva (Semmelweis University. Department of Genetics, Cell- and Immunobiology) ;
Del Portillo, Hernando A.. (Institució Catalana de Recerca i Estudis Avançats) ;
Reventós, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rohde, Eva (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine (Salzburg)) ;
Sammar, Marei (ORT Braude College. Department of Biotechnology Engineering) ;
Sánchez-Madrid, Francisco (Instituto de Investigación Hospital Universitario de la Princesa) ;
Santarém, N. (IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto) ;
Schallmoser, Katharina (Uniklinikum Salzburg. University Clinic of Blood Group Serology and Transfusion Medicine) ;
Ostenfeld, Marie Stampe (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Stoorvogel, Willem (Utrecht University. Department of Biochemistry and Cell Biology) ;
Stukelj, Roman (University of Ljubljana. Laboratory of Clinical Biophysics) ;
Van der Grein, Susanne G. (Utrecht University. Department of Biochemistry and Cell Biology) ;
Vasconcelos, M. Helena (University of Porto. Department of Biological Sciences) ;
Wauben, Marca H. M. (Utrecht University. Department of Biochemistry and Cell Biology) ;
De Wever, Olivier (Universitair Ziekenhuis Gent) ;
Universitat Autònoma de Barcelona
In the past decade, extracellular vesicles (EVs) have been recognized as potent vehicles of intercellular communication, both in prokaryotes and eukaryotes. This is due to their capacity to transfer proteins, lipids and nucleic acids, thereby influencing various physiological and pathological functions of both recipient and parent cells. [...]
2015 - 10.3402/jev.v4.27066
Journal of extracellular vesicles, Vol. 4 (2015)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
